No CrossRef data available.
Article contents
SHEA position statement on pandemic preparedness for policymakers: emerging infectious threats
Published online by Cambridge University Press: 19 July 2024
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- SHEA Position Paper
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
Morse, SS. Factors in the emergence of infectious diseases. Emerg Infect Dis 1995;1:7–15. doi: 10.3201/eid0101.950102.CrossRefGoogle ScholarPubMed
Morens, DM, Fauci, AS. Emerging pandemic diseases: How we got to covid-19. Cell 2020;182:1077–1092. doi: 10.1016/j.cell.2020.08.021.CrossRefGoogle ScholarPubMed
Degeling, C, Johnson, J, Kerridge, I, et al. Implementing a One Health approach to emerging infectious disease: Reflections on the socio-political, ethical and legal dimensions. BMC Public Health 2015;15:1307. doi: 10.1186/s12889-015-2617-1.CrossRefGoogle ScholarPubMed
Merced-Morales, A, Daly, P, Abd Elal, AI, et al. Influenza activity and composition of the 2022–23 influenza vaccine – United States, 2021–22 season. MMWR Morb Mortal Wkly Rep 2022;71:913–919. doi: 10.15585/mmwr.mm7129a1.CrossRefGoogle ScholarPubMed
Mora, C, McKenzie, T, Gaw, IM, et al. Over half of known human pathogenic diseases can be aggravated by climate change. Nat Clim Chang 2022;12:869–875. doi: 10.1038/s41558-022-01426-1.CrossRefGoogle ScholarPubMed
Edelson, PJ, Harold, R, Ackelsberg, J, et al. Climate change and the epidemiology of infectious diseases in the United States. Clin Infect Dis 2023;76:950–956. doi: 10.1093/cid/ciac697.CrossRefGoogle ScholarPubMed
Casadevall, A, Kontoyiannis, DP, Robert, V. On the emergence of Candida auris: Climate change, azoles, swamps, and birds. mBio 2019;10. doi: 10.1128/mBio.01397-19.CrossRefGoogle Scholar
Rosenberg, R, Lindsey, NP, Fischer, M, et al. Vital signs: Trends in reported vectorborne disease cases – United States and territories, 2004–2016. MMWR Morb Mortal Wkly Rep 2018;67:496–501. doi: 10.15585/mmwr.mm6717e1.CrossRefGoogle ScholarPubMed
Bambra, C. Pandemic inequalities: Emerging infectious diseases and health equity. Int J Equity Health 2022;21:6. doi: 10.1186/s12939-021-01611-2.CrossRefGoogle ScholarPubMed
US House of Representatives Select Subcommittee on the Coronavirus Crisis. Preparing for and preventing the next public health emergency: Lessons learned from the coronavirus crisis. Washington, D.C., 2022.Google Scholar
Daszak, P, Keusch, GT, Phelan, AL, Johnson, CK, Osterholm, MT. Infectious disease threats: A rebound to resilience. Health Aff (Millwood) 2021;40:204–211. doi: 10.1377/hlthaff.2020.01544.CrossRefGoogle ScholarPubMed
Kava, CM, Rohraff, DM, Wallace, B, et al. Epidemiologic features of the monkeypox outbreak and the public health response – United States, May 17–October 6, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1449–1456. doi: 10.15585/mmwr.mm7145a4.CrossRefGoogle Scholar
McQuiston, JH, Braden, CR, Bowen, MD, et al. The CDC domestic Mpox response – United States, 2022–2023. MMWR Morb Mortal Wkly Rep 2023;72:547–552. doi: 10.15585/mmwr.mm7220a2.CrossRefGoogle ScholarPubMed
Eckelman, MJ, Huang, K, Lagasse, R, et al. Health care pollution and public health damage in the United States: An update. Health Aff (Millwood) 2020;39:2071–2079.CrossRefGoogle Scholar